Einfache Stichwortsuche: Stichwort/Text (mindestens 3 Zeichen)
Erweiterte Stichwortsuche:
1. Stichwort1/Text1 AND Stichwort2/Text2 (= Suchergebnis muss beide Stichwörter/Texte enthalten! 1 und 2!)
2. Stichwort1/Text1 OR Stichwort2/Text2 (= Suchergebnis muss entweder 1 oder 2 enthalten)

Zurücksetzen
2024
Feichtenschlager, V., Chen, L., Zheng, Y. J., Ho, W., Sanlorenzo, M., Vujic, I., Fewings, E., Et Al, ., Kohwi, Y., Posch, C., Rappersberger, K., Kohwi-Shigematsu, T., Coppe, J. P., & Ortiz-Urda, S. (2024). The therapeutically actionable long non-coding RNA ' T-RECS' is essential to cancer cells' survival in NRAS/MAPK-driven melanoma. Res Sq, 23(1), 40. doi: 10.21203/rs.3.rs-1297358/v3 (IF: 37.3)
Richtig, E., Nguyen, V. A., Koelblinger, P., Wolf, I., Kehrer, H., Et Al, ., Weihsengruber, F., Rappersberger, K., Svastics, N., Gasser, K., Seeber, A., Kratochvill, F., Nagler, S., Mraz, B., & Hoeller, C. (2024). Dabrafenib plus trametinib in unselected advanced BRAF V600-mut melanoma: a non-interventional, multicenter, prospective trial. Melanoma Res, 34(2), 142-151. doi: 10.1097/CMR.0000000000000948 (IF: 2.2)
Wiala, A., Daschl, S. M., Stockinger, T., Rappersberger, K., & Posch, C. (2024). Oral fusidic acid for the treatment of mild-to-moderate hidradenitis suppurativa. Int J Dermatol, -(-), -. doi: 10.1111/ijd.17115 (IF: 3.6)
2023
Feichtenschlager, V., Chen, L., Zheng, Y. J., Ho, W., Sanlorenzo, M., Vujic, I., Fewings, E., Lee, A., Chen, C., Et Al, ., Posch, C., Daud, A., Rappersberger, K., Kohwi-Shigemtsu, T., Coppé, J. P., & Ortiz-Urda, S. (2023). The therapeutically actionable long non-coding RNA ' T-RECS' is essential to cancer cells' survival in NRAS/MAPK-driven melanoma. Res Sq, -(-), -. doi: 10.21203/rs.3.rs-1297358/v3
Feichtenschlager, V., Zheng, Y. J., Ho, W., Chen, L., Callanan, C., Lee, A., Ortiz, J., Rappersberger, K., & Ortiz-Urda, S. (2023). Deconstructing the role of MALAT1 in MAPK-signaling in melanoma: insights from antisense oligonucleotide treatment. Oncotarget, -(-), 543-560. doi: 10.18632/oncotarget.28447
Wiala, A., Rappersberger, K., & Monshi, B. (2023). The role of histopathology in a case of adult-onset linear cutaneous lupus. J Dtsch Dermatol Ges, 21(1), 66-68. doi: 10.1111/ddg.14928 (IF: 3.9)
Wiala, A., Rappersberger, K., & Monshi, B. A. (2023). Die Rolle der Histopathologie in einem Fall von linearem kutanem Lupus im Erwachsenenalter. J Dtsch Dermatol Ges, 21(1), 66-68. doi: 10.1111/ddg.14928_g (IF: 3.9)
2022
Perschy, L., Anzengruber, F., Rappersberger, K., Itzlinger-Monshi, B., Aichelburg, M. C., Graf, V., Hafner, J., & Vujic, I. (2022). Apremilast bei oralem Lichen planus - eine multizentrische, retrospektive Studie. J Dtsch Dermatol Ges, 20(3), 343-348. doi: 10.1111/ddg.14696_g
Zheng, Y. J., Ho, W., Sanlorenzo, M., Vujic, I., Daud, A., Algazi, A., Rappersberger, K., & Ortiz-Urda, S. (2022). Melanoma risk during immunomodulating treatment. Melanoma Res, 32(6), 411-418. doi: 10.1097/CMR.0000000000000838
2021
Kirchler, C., Husar-Memmer, E., Rappersberger, K., Thaler, K., & Fritsch-Stork, R. (2021). Type I Interferon as cardiovascular risk factor in systemic and cutaneous lupus erythematosus: A systematic review. Type I Interferon as cardiovascular risk factor in systemic and cutaneous lupus erythematosus: A systematic review, 20(5), 102794. doi: 10.1016/j.autrev.2021.102794
Monshi, B., Ellersdrofer, C., Edelmayer, M., Dvorak, G., Ganger, C., Ulm, C., Rappersberger, K., & Vujic, I. (2021). Department of Dermatology and Venereology, Klinik Landstraße, Juchgasse 25, 1030 Vienna, Austria. J Clin Med, 10(22), 5454. doi: 10.3390/jcm10225454
Monshi, B., Grabovac, S., Gulz, L., Ellersdorfer, C., Vujic, M., Richter, L., Kivaranovic, D., Rappersberger, K., & Vujic, I. (2021). Psoriasis is associated with fissured tongue but not geographic tongue: a prospective, cross-sectional, case-control study. J Dtsch Dermatol Ges, 19(8), 1170-1177. doi: 10.1111/ddg.14451
Monshi, B., Grabovac, S., Gulz, L., Ellersdorfer, C., Vujic, M., Richter, L., Kivaranovic, D., Rappersberger, K., & Vujic, I. (2021). Psoriasis ist mit Lingua plicata jedoch nicht mit Lingua geographica assoziiert: eine prospektive Fall-Kontroll-Studie. J Dtsch Dermatol Ges, 19(8), 1170-1177. doi: 10.1111/ddg.14451_g
Schiffmann, M. L., Dissemond, J., Erfurt-Berge, C., Hafner, J., Itzlinger-Monshi, B. A., Jungkunz, H. W., Kahle, B., Kreuter, A., Scharffetter-Kochanek, K., Lutze, S., Rappersberger, K., Schneider, S. W., & Et Al, . (2021). S1-Leitlinie Diagnostik und Therapie der Livedovaskulopathie. J Dtsch Dermatol Ges, 19(11), 1667-1678. doi: 10.1111/ddg.14520_g
Schiffmann, M. L., Dissemond, J., Erfurt-Berge, C., Hafner, J., Itzlinger-Monshi, B. A., Jungkunz, H. W., Kahle, B., Kreuter, A., Scharffetter-Kochanek, K., Lutze, S., Rappersberger, K., Schneider, S. W., Strölin, A., Sunderkötter, C., & Goerge, T. (2021). German S1 guideline: diagnosis and treatment of livedovasculopathy. N Dtsch Dermatol Ges, 19(11), 1668-1678. doi: 10.1111/ddg.14520
Wiala, A., Vujic, I., Richter, L., Rappersberger, K., & Posch, C. (2021). Dermatomyositis requires long-term treatment with combined immunosuppressive and immunoglobulin therapy. J Dtsch Dermatol Ges, 19(3), 456-458. doi: 10.1111/ddg.14365_g
2020
Monshi, B., Gulz, L., Piringer, B., Wiala, A., Kivaranovic, D., Schmidt, M., Sesti, A., Heil, T., Vujic, I., Posch, C., & Rappersberger, K. (2020). Anti-BP180 autoantibody levels at diagnosis correlate with 1-year mortality rates in patients with bullous pemphigoid. J Eur Acad Dermatol Venereol, 34(7), 1583-1589. doi: 10.1111/jdv.16363
Vujic, I., Gandini, S., Stanganelli, I., Fierro, M. T., Rappersberger, K., Sibilia, M., Tosti, G., Ferrucci, P. F., Caini, S., De Felici, M. B., Pagliarello, C., Quaglino, P., Sanlorenzo, M., & Imi, T. I. M. I. (2020). A Meta-Analysis of Melanoma Risk in Industrial Workers. Melanoma Res., 30(3), 286-296. doi: 10.1097/CMR.0000000000000531
2019
Feichtenschlager, V., Weihsengruber, F., Richter, L., Vujic, I., Rappersberger, K., & Posch, C. (2019). Clinical melanoma characteristics and survival-a single-center retrospective study between 2000 and 2010. Wien Med Wochenschr, 169(13-14), 323-330. doi: 10.1007/s10354-018-0678-3
Grieb, A., Kaderschabek, N., Orasche, C., Minkov, M., Sanlorenzo, M., Rappersberger, K., & Vujic, I. (2019). Mycoplasma pneumoniae-associated mucositis with cutaneous involvement - a case report. J Dtsch Dermatol Ges, 17(2), 184-185. doi: 10.1111/ddg.13714 (IF: 3.9)
Platzer, K. D., Kostner, L., Vujic, I., Monshi, B., Richter, L., Rappersberger, K., & Posch, C. (2019). Clinical characteristics and treatment outcomes of 36 pyoderma gangrenosum patients - a retrospective, single institution observation. J Eur Acad Dermatol Venereol, 33(7), Epub ahead of print. doi: 10.1111/jdv.15803 (IF: 4.287)
2018
Sanlorenzo, M., Vujic, I., Esteve-Puig, R., Lin, K., Posch, C., Dimon, M., Moy, A., Zekhtser, M., Johnston, K., Gho, D., Ho, W., Gajjala, A., Oses Prieto, J., Burlingame, A., Daud, A., Rappersberger, K., & Ortz-Urda, S. (2018). The lincRNA MIRAT binds to IQGAP1 and modulates the MAPK pathway in NRAS mutant melanoma. Scientific Reports, 8(1), 10902. doi: 10.1038/s41598-018-27643-3 (IF: 4,12)
2017
Bal, C., Rappersberger, K., & Posch, C. (2017). Adverse effects of subcutaneous, drug-releasing implants for the treatment of opioid drug addiction. J Dtsch Dermatol Ges, 15(12), 1232-1234. doi: 10.1111/ddg.13319
Kwong, A., Sanlorenzo, M., Rappersberger, K., & Vujic, I. (2017). Update on advanced melanoma treatments: small molecule targeted therapy, immunotherapy, and future combination therapies. Wien Klin Wochenschrift, pp(1-9), epub. doi: 10.1007/s10354-016-0535-1
Posch, C., Monshi, B., Quint, T., Vujic, I., Lilgenau, N., & Rappersberger, K. (2017). The role of wide local excision for the treatment of severe hidradenitis suppurativa (Hurley grade III): Retrospective analysis of 74 patients. J Am Acad Dermatol, 77(1), 123-129. doi: 10.1016/j.jaad.2017.01.055